Endpoints News – Biotech and pharma business news, with a focus …
Heartbreaking anecdotes from the patients, parents and doctors of children with the ultra-rare and fatal Barth syndrome won over an FDA advisory committee on Thurs ...
Endpoints at #JPM24 | Primed to unlock biopharma's next …
The Endpoints Hub will be open for coworking & networking — power up your devices, check email and grab coffee and a bite between session. On Tuesday, you’ll go to biotech downturn survival school, hear about the data private investors expect to see in a tricky capital market and find out the future plans for pharma from top execs in the ...
Big dreams dominate among next-gen biotech players
Sep 22, 2024 — Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change. This marks Carroll’s 20th year selecting top private biotechs for special recognition. Join us at this special event in Boston to recognize this year’s group. sponsored by. see the winners.
Endpoints 11 - Biopharma's Most Promising Startups in 2021
Sep 22, 2024 — The biotech 2.0 era has arrived. And with that backdrop, we'll unveil the top 11 companies supercharging a new generation of startups in 2021. Watch John Carroll & John Chiminski as they talk biotech with the teams behind the winning companies and learn what defines the Endpoints 11.
News – Endpoints News
Immatics heads to Phase 3 with melanoma cell therapy, seeks to raise $150M. 1 hour ago. Financing. R&D.
About Endpoints News – Endpoints News
John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 20 years. Aside from ...
Eli Lilly invests in Superluminal’s $120M Series A round as AI …
Sep 9, 2024 — Superluminal Medicines joined the ranks of AI-focused biotechs hauling in megarounds, closing an RA Capital-led $120 million Series A, the startup said Monday.
Endpoints Careers - Find your next biopharma job
Endpoints Careers is where biopharma career seekers and employers connect. All jobs have been curated by Endpoints or posted by employers directly to ensure the highest quality. Free basic job postings for companies seeking talent. Find your career today! High quality job postings for business and science leaders in biopharma.
Endpoints at #JPM22 - A look at what's to come in 2022
Endpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies. For #JPM22, Endpoints is expanding on our proud tradition with multiple panels addressing the most important issues in biopharma R&D. title sponsor.
It’s mission critical this time as biotech looks to bounce back
Now it’s time to fix that. Getting together, exploring new deals, hoping someone uncorks a whopper of a buyout, all while assessing the year ahead — these are all annual traditions set to make a comeback at the start of 2023. And this year Endpoints News will be at the heart of it all, offering a hybrid slate of events that will be both ...